Federation Des Caisses Desjardins Du Quebec Nkarta, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Nkarta, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 100 shares of NKTX stock, worth $181. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$181
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NKTX
# of Institutions
121Shares Held
61.1MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$19.6 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$7.35 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$6.82 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.46 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$6.45 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $88.1M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...